Page last updated: 2024-09-04

rhodioloside and oxidopamine

rhodioloside has been researched along with oxidopamine in 2 studies

Compound Research Comparison

Studies
(rhodioloside)
Trials
(rhodioloside)
Recent Studies (post-2010)
(rhodioloside)
Studies
(oxidopamine)
Trials
(oxidopamine)
Recent Studies (post-2010) (oxidopamine)
62125198,63062,407

Protein Interaction Comparison

ProteinTaxonomyrhodioloside (IC50)oxidopamine (IC50)
Glyceraldehyde-3-phosphate dehydrogenaseHomo sapiens (human)8
DNA repair protein RAD52 homologHomo sapiens (human)0.779

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Feng, D; Huang, L; Lai, J; Lu, F; Nie, T; Tao, K; Wang, B; Yang, Q; Zhang, W1
Fan, SH; Han, XR; Hu, B; Li, MQ; Lu, J; Shan, Q; Sun, CH; Wang, S; Wang, YJ; Wen, X; Wu, DM; Zhang, ZF; Zheng, YL; Zhuang, J1

Other Studies

2 other study(ies) available for rhodioloside and oxidopamine

ArticleYear
Salidroside Protects Against 6-Hydroxydopamine-Induced Cytotoxicity by Attenuating ER Stress.
    Neuroscience bulletin, 2016, Volume: 32, Issue:1

    Topics: Adrenergic Agents; Animals; Apoptosis; Blotting, Western; Cell Line; Cell Survival; Dopaminergic Neurons; Endoplasmic Reticulum Stress; Glucosides; Immunohistochemistry; In Situ Nick-End Labeling; Mice; Neuroprotective Agents; Oxidopamine; Parkinsonian Disorders; Phenols; Rats; Rats, Sprague-Dawley

2016
Salidroside Protection Against Oxidative Stress Injury Through the Wnt/β-Catenin Signaling Pathway in Rats with Parkinson's Disease.
    Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology, 2018, Volume: 46, Issue:5

    Topics: Animals; Antioxidants; Apoptosis; Female; Glucosides; Male; Neuroprotective Agents; Oxidative Stress; Oxidopamine; Parkinson Disease, Secondary; PC12 Cells; Phenols; Rats; Rats, Wistar; Wnt Signaling Pathway

2018